Product Name:

VEGFR3-1


Product Number:

ab-nk063-4

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3

Target Alias: Fms-related tyrosine kinase 4; PCL; Tyrosine-protein kinase receptor FLT4; FLT41; VEGFR3; VGFR3; VGR3; CCDS4457.1; ENSG00000037280

Product Type Specific: Protein kinase pan-specific antibody

Antibody Code: NK064-2

Antibody Target Type: Pan-specific

Protein UniProt: P35916

Protein SigNET: P35916

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human VEGFR3 (Flt4) sequence peptide Cat. No.: PE-01AVP95

Antibody Immunogen Sequence: CNELYDIQLLPRKSLE

Antibody Immunogen Description: Corresponds to amino acid residues N227 to E241

Production Method: Corresponds to amino acid residues N227 to E241

Antibody Modification: Protein kinase pan-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Very strong immunoreactivity with recombinant human VEGFR3 on protein dot blots.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 160-175 kDa.

Antibody Specificity: Very high

Antibody Cross Reactivity: Weak immunoreactivity on protein dot blots with recombinant human VGFR1, and no immunoreactivity with recombinant human VGFR2.

Scientific Background: VEGFR3 (Flt4) is a protein-tyrosine kinase of the TK group and VEGFR family. It is a receptor for vascular endothelial growth factors (VEGF) C and D that is essential in angiogenesis and vasculogenesis. It is activated by binding VEGF-C and VEGF-D, which induce dimerization and autophosphorylation. VEGFR3 plays critical roles in some lymphangiogenetic mechanisms in cancer and metastasis. It is expressed in acute myeloid leukemia and other types of cancer, and are related to tumour angiogenesis and efficacy of traditional therapies.